5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.57▼ | 2.57▼ | 2.57▼ | 2.56▼ | 2.61▼ |
MA10 | 2.54▼ | 2.55▼ | 2.55▼ | 2.58▼ | 2.62▼ |
MA20 | 2.57▼ | 2.62▼ | 2.62▼ | 2.64▼ | 2.82▼ |
MA50 | 2.66▼ | 2.59▼ | 2.59▼ | 2.63▼ | 2.35▲ |
MA100 | 2.61▼ | 2.68▼ | 2.71▼ | 2.82▼ | 2.44▲ |
MA200 | 2.75▼ | 2.89▼ | 2.89▼ | 2.39▲ | 8.63▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.009▼ | -0.009▼ | -0.011▼ | -0.063▼ |
RSI | 43.586▼ | 45.385▼ | 45.580▼ | 43.436▼ | 46.972▼ |
STOCH | 70.139 | 58.848 | 58.848 | 39.125 | 35.857 |
WILL %R | -55.000 | -55.000 | -55.000 | -66.102 | -75.904▼ |
CCI | -32.099 | -37.967 | -37.967 | -79.600 | -74.519 |
Tuesday, April 23, 2024 04:00 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
Tuesday, April 23, 2024 03:12 PM
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells.
|
Tuesday, April 23, 2024 01:59 PM
Real-time Data is provided using Nasdaq Last Sale Data Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/04/24 | 2.53 | 2.5701 | 2.48 | 2.50 | 39,301 |
23/04/24 | 2.46 | 2.6497 | 2.46 | 2.6197 | 47,230 |
22/04/24 | 2.59 | 2.65 | 2.59 | 2.64 | 23,573 |
19/04/24 | 2.58 | 2.58 | 2.5101 | 2.55 | 11,743 |
18/04/24 | 2.53 | 2.63 | 2.30 | 2.47 | 14,990 |
17/04/24 | 2.57 | 2.61 | 2.4511 | 2.46 | 6,942 |
16/04/24 | 2.50 | 2.65 | 2.4854 | 2.49 | 84,326 |
15/04/24 | 2.59 | 2.65 | 2.53 | 2.61 | 41,919 |
12/04/24 | 2.80 | 2.80 | 2.67 | 2.69 | 60,116 |
11/04/24 | 2.81 | 2.855 | 2.78 | 2.80 | 14,726 |
|
|
||||
|
|
||||
|
|